Use of long-acting injectable risperidone before and throughout pregnancy in schizophrenia |
| |
Authors: | Kim Sung-Wan Kim Ki-Min Kim Jae-Min Shin Il-Seon Shin Hee-Young Yang Su-Jin Yoon Jin-Sang |
| |
Affiliation: | Department of Psychiatry, Chonnam National University Medical School, 5 Hak-dong, Dong-ku, Kwangju 501-746, Republic of Korea. |
| |
Abstract: | Data on the use of long-acting injectable (LAI) risperidone, the first atypical depot antipsychotic, during pregnancy are limited. A 35-year-old woman with schizophrenia was given LAI risperidone before and throughout her pregnancy. She gave birth to a female infant weighing 2230 g at 36 weeks and 6 days of pregnancy, following premature rupture of the membranes. The baby had no congenital malformation and was healthy 8 months postnatal. To our knowledge, this is the first reported use of LAI risperidone throughout an entire pregnancy. In this paper, we discuss the rationale and problems of LAI risperidone use in pregnancy, based on a literature review. |
| |
Keywords: | LAI risperidone, long-acting injectable risperidone APGAR, activity, pulse, grimace, appearance, respiration |
本文献已被 ScienceDirect PubMed 等数据库收录! |
|